Admission respiratory status predicts mortality in COVID-19.
Influenza Other Respir Viruses
; 15(5): 569-572, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1241010
ABSTRACT
COVID-19 has significant case fatality. Glucocorticoids are the only treatment shown to improve survival, but only among patients requiring supplemental oxygen. WHO advises patients to seek medical care for "trouble breathing," but hypoxemic patients frequently have no respiratory symptoms. Our cohort study of hospitalized COVID-19 patients shows that respiratory symptoms are uncommon and not associated with mortality. By contrast, objective signs of respiratory compromise-oxygen saturation and respiratory rate-are associated with markedly elevated mortality. Our findings support expanding guidelines to include at-home assessment of oxygen saturation and respiratory rate in order to expedite life-saving treatments patients to high-risk COVID-19 patients.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Oxígeno
/
Enfermedades Respiratorias
/
Frecuencia Respiratoria
/
COVID-19
Tipo de estudio:
Estudio de cohorte
/
Estudios diagnósticos
/
Estudio observacional
/
Estudio pronóstico
Límite:
Adulto
/
Anciano
/
Femenino
/
Humanos
/
Masculino
/
Middle aged
Idioma:
Inglés
Revista:
Influenza Other Respir Viruses
Asunto de la revista:
Virología
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Irv.12869
Similares
MEDLINE
...
LILACS
LIS